Orthofix International NV (NASDAQ:OFIX)

31.51
Data as of Apr 17
 +0.29 / +0.93%
Today’s Change
19.35
Today|||52-Week Range
33.67
+38.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$576.9M

Company Description

Orthofix International NV is a global medical device company. It focuses on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic market along with offering a portfolio of non-invasive products to treat a variety of sports medicine related conditions in order to minimize pain and restore mobility. The company designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. It operates through two business segment: Spine and Orthopedics. The Spine business segment provides a portfolio of repair and regenerative products that allow physicians to treat a variety of spinal conditions. In addition, it also specializes in the design, development and marketing of the spinal repair products along with regenerative stimulation and biologics products used in spine applications. The Orthopedics business segment provides a portfolio of repair and regenerative products that allow physicians to successfully treat a variety of orthopedic conditions unrelated to spine. This global business unit specializes in the design, development and marketing of the company's orthopedic repair products along with regeneration stimulation and biologics products used in orthopedic applications. The company's products are used to bone growth and the success rate of spinal fusions and to treat non-union fractures, external and internal fixation devices used in fracture repair, limb lengthening and bone reconstruction. Its products include bone cement and devices for removal of bone cement used to fix artificial implants. Orthofix International was founded on October 19, 1987 and is headquartered in Willemstad, Netherlands.

Contact Information

Orthofix International NV
7 Abraham de Veerstraat
Willemstad Curacao --
P:3159994658525
Investor Relations:
(214) 937-2924

Employees

Shareholders

Other institutional61.93%
Mutual fund holders30.63%
Individual stakeholders14.14%

Top Executives

Bradley R. MasonPresident, Chief Executive Officer & Director
Vicente TrellesEVP-Worldwide Operations, Research & Development
Emily BuxtonChief Financial Officer
Chuck JaggersGlobal Vice President-Research & Development
Jeffrey Michael SchummSecretary, Chief Administrative Officer & SVP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.